WEBINAR:

Guiding Oncology Drug Development with Xsphera’s Human Tissue Platform and the IO 360 Panel

Watch Now for an in-depth webinar where we explore how the nCounter PanCancer IO 360 Panel can illuminate diverse responses to multiple oncology therapeutics, both within and across human tissue samples. Kevin Horrigan will present Xsphera’s human tissue ex vivo platform and share case studies highlighting how the IO 360 panel characterizes post-treatment molecular responses across a range of drug modalities.

The IO 360 assay provides a fast, highly sensitive method to gain deep insight into cell abundance, cytotoxic efficacy, mechanisms of action, and mechanisms of tumor resistance. This session is ideal for translational researchers, oncology scientists, and anyone interested in leveraging high-dimensional RNA profiling to guide therapeutic development and develop biomarkers for identifying responders versus non-responders.

Meet Our Speaker! 

Kevin Horrigan, M.E.M. VP Software and Operations Xsphera Biosciences

ABOUT KEVIN:

Kevin joined Xsphera Bioscience in 2020 and built Xsphera’s Cloud analytics platform from the ground up, enabling automated and flexible, multi-omic data processing and visualization. He is currently integrating advanced AI and machine learning to model tumor response and identify predictive biomarkers. Kevin also oversees biospecimen and clinical tissue operations, ensuring the generation of high-quality data to drive these models. Prior to Xsphera, he held leadership roles at Dassault Systèmes and Exa Corporation, where he developed and deployed high-performance cloud computing services for global industrial product development. Kevin earned a Master’s in Engineering Management and a Bachelor of Engineering from Dartmouth College.

Xsphera Bioscience is a Boston-based start-up company that leverages a proprietary microfluidic platform, originally developed at Dana-Farber, to profile the response of multiple therapeutics on freshly resected human tumor tissue, generating rich datasets for AI-driven insights.

Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed sit amet finibus nulla. Integer a ligula viverra, dapibus mi eu, volutpat purus. Praesent posuere et risus nec bibendum. Curabitur quam nibh, maximus lobortis tortor ac, congue pulvinar augue. Pellentesque pretium mauris eget imperdiet laoreet.

Lorem Ipsum Dolor Sit Amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed sit amet finibus nulla. Integer a ligula viverra, dapibus mi eu, volutpat purus. Praesent posuere et risus nec bibendum. Curabitur quam nibh, maximus lobortis tortor ac, congue pulvinar augue. Pellentesque pretium mauris eget imperdiet laoreet.

Bonus Presentation: Whole transcriptome spatial molecular imaging in matched pre and post treatment specimens to identify therapeutic vulnerabilities and treatment-associated effects in pancreatic

Dr. Will Hwang shared his data at the most recent AACR event and we will re-air his presentation for you here.  This research highlights new strategies for analyzing whole-transcriptome spatial transcriptomics at subcellular resolution and the potential thereof to identify novel treatment-associated effects. You won’t want to miss it.

Presenter: Will Hwang, MD, PhD Assistant Professor, Harvard Medical School; Principal Investigator, Massachusetts General Hospital; Associate Faculty Member, Broad Institute of MIT and Harvard

Register Today!